$17.47 (2.77%)

Volume: 1.014M

Closed: Dec 02, 2022

Hollow Logo Score: 2.315

Exelixis Stock Forecast

$17.47 (2.77%)

Volume: 1.014M

Closed: Dec 02, 2022

Score Hollow Logo 2.315

Exelixis Stock Statistics NASDAQ:EXEL

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Dates Signal Change
2022-12-02 - 2022-12-02 BUY 0
2022-11-30 - 2022-12-02 HOLD 2.92
2022-11-29 - 2022-11-30 SELL 3.07
2022-11-28 - 2022-11-29 HOLD -1.67
2022-11-25 - 2022-11-28 SELL -1.15

Stock Score Effectiveness

Bollinger Stock Signal Effectiveness

Macd Signal Effectiveness

Mv7 Signal Effectiveness

Score signal

Bollinger Signal Statistics

MV signal statistics

MACD Signal Statistics

Hot Stocks To Watch:

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE